Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option

BMC Gastroenterology

Debate

Stacy M Carter¹  Kathy L Flitcroft¹  Les M Irwig¹  Glenn P Salkeld¹  James A Gillespie¹ 

[1] Sydney School of Public Health, Edward Ford Building, A28 University of Sydney, 2006, Sydney, NSW, Australia;

关键词: Screening objectives;    Colorectal cancer;    Fecal occult blood testing;    Harm minimization;    Equity;    Economic efficiency;    Prevention;    Participation;   

DOI  :  10.1186/1471-230X-12-183

 received in 2012-05-28, accepted in 2012-12-14,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundThere are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening.DiscussionWhile all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening.SummaryApplying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives.

【 授权许可】

CC BY   
© Flitcroft et al.; licensee BioMed Central Ltd. 2012